Source guides · 1
- (COVID-19) SARS-CoV-2-catatonia syndrome: does it exist? Longitudinal evidence. · Full Atlas view
- (COVID-19) SARS-CoV-2-catatonia syndrome: does it exist? Longitudinal evidence. · Full Atlas view
- (COVID-19) SARS-CoV-2-catatonia syndrome: does it exist? Longitudinal evidence. · Full Atlas view
- (GluEsk) Glutamate and Esketamine · Full Atlas view
- 1955 study in chronic schizophrenia · Full Atlas view
- 2025 review of psychotic depression · Full Atlas view
- 2026 review of ketamine and schizophrenia · Full Atlas view
- 2026 review of mood disorders with psychosis · Full Atlas view
- 2026 tobacco crossover study · Full Atlas view
- 404. Hyperactive catatonia in autism and schizoaffective disorder: diagnostic pitfalls and pharmacological insights · Full Atlas view
- 404. Hyperactive catatonia in autism and schizoaffective disorder: diagnostic pitfalls and pharmacological insights · Full Atlas view
- 416. Management of treatment-resistant catatonia: alternative therapeutic strategies · Full Atlas view
- 416. Management of treatment-resistant catatonia: alternative therapeutic strategies · Full Atlas view
- 5-MeO-DMT clinical pharmacology and safety review · Full Atlas view
- 5-MeO-DMT survey of reported benefits and adverse effects · Full Atlas view
- 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide · Full Atlas view
- 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide · Full Atlas view
- A 6-Year-Old With Becker Muscular Dystrophy and Catatonia. · Full Atlas view
- A 6-Year-Old With Becker Muscular Dystrophy and Catatonia. · Full Atlas view
- A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review. · Full Atlas view
- A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review. · Full Atlas view
- A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review. · Full Atlas view
- A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient. · Full Atlas view
- A Case of Cannabis-Induced Catatonia and Management With Electroconvulsive Therapy. · Full Atlas view
- A Case of Cannabis-Induced Catatonia and Management With Electroconvulsive Therapy. · Full Atlas view
- A Case of Cannabis-Induced Catatonia and Management With Electroconvulsive Therapy. · Full Atlas view
- A Case of N-Methyl-D-Aspartate (NMDA) Autoimmune Encephalitis in a 34-Year-Old Man Thought to Have Schizophrenia. · Full Atlas view
- A Case of Neuropsychiatric Lupus With Severe Malignant Catatonia that Improved With Daily Electroconvulsive Therapy. · Full Atlas view
- A Case of Neuropsychiatric Lupus With Severe Malignant Catatonia that Improved With Daily Electroconvulsive Therapy. · Full Atlas view
- A Case of Nonmalignant Delirious Mania Successfully Treated With Lorazepam and Carbamazepine: A Proposed Diagnostic and Treatment Algorithm. · Full Atlas view
- A Case of Ovarian Teratoma-Induced N-Methyl-D-Aspartate Receptor Antibody Encephalitis Presenting With Psychosis and Catatonia, Progressing to the Minimally Conscious State and Successfully Treated With Adjunctive Zolpidem. · Full Atlas view
- A Case of Prolonged Catatonia Caused by Sjögren's Syndrome. · Full Atlas view
- A Case of Prolonged Catatonia Caused by Sjögren's Syndrome. · Full Atlas view
- A Case of Prolonged Catatonia Caused by Sjögren's Syndrome. · Full Atlas view
- A Case of Recurrent Hypersomnia With Autonomic Dysfunction. · Full Atlas view
- A Case of Schizophrenia with Diagnostic Challenges Between Non-convulsive Status Epilepticus and Malignant Catatonia: Therapeutic Implications based on the GABA-A Dysfunction Hypothesis. · Full Atlas view
- A Case of Schizophrenia with Diagnostic Challenges Between Non-convulsive Status Epilepticus and Malignant Catatonia: Therapeutic Implications based on the GABA-A Dysfunction Hypothesis. · Full Atlas view
- A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia · Full Atlas view
- A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression · Full Atlas view
- A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia · Full Atlas view
- A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms · Full Atlas view
- A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence · Full Atlas view
- A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide · Full Atlas view
- A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression · Full Atlas view
- A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment · Full Atlas view
- A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder · Full Atlas view
- A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression · Full Atlas view
- A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression · Full Atlas view
- A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD · Full Atlas view
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) · Full Atlas view
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2) · Full Atlas view
- A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders · Full Atlas view
- A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD · Full Atlas view
- A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine · Full Atlas view
- A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders · Full Atlas view
- A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD) · Full Atlas view
- A Phase 2A Trial of DT402 for Autism Spectrum Disorder · Full Atlas view
- A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) · Full Atlas view
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) · Full Atlas view
- A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) · Full Atlas view
- A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD · Full Atlas view
- A Rapid Solution: The Midazolam Challenge as an Alternative to Lorazepam for Catatonia in the Intensive Care Unit. · Full Atlas view
- A Rapid Solution: The Midazolam Challenge as an Alternative to Lorazepam for Catatonia in the Intensive Care Unit. · Full Atlas view
- A Rare Presentation of Severe Hypothyroidism With Catatonia and Psychosis: Myxedema Madness. · Full Atlas view
- A Rare Presentation of Severe Hypothyroidism With Catatonia and Psychosis: Myxedema Madness. · Full Atlas view
- A Rare Presentation of Severe Hypothyroidism With Catatonia and Psychosis: Myxedema Madness. · Full Atlas view
- A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health · Full Atlas view
- A Reversible Isolated Lesion in the Splenium of Corpus Callosum in a Patient with Probable Neuroleptic Malignant Syndrome -- Case Report. · Full Atlas view
- A Single Ketamine Infusion Combined With Music for Suicidal Ideation · Full Atlas view
- A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive Episodes · Full Atlas view
- A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers · Full Atlas view
- A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) · Full Atlas view
- A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression · Full Atlas view
- A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression · Full Atlas view
- A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression · Full Atlas view
- A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression · Full Atlas view
- A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression · Full Atlas view
- A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients · Full Atlas view
- A Study of Ketamine as an Antidepressant · Full Atlas view
- A Study of Ketamine in Patients With Treatment-resistant Depression · Full Atlas view
- A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide · Full Atlas view
- A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression · Full Atlas view
- A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) · Full Atlas view
- A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) · Full Atlas view
- A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression · Full Atlas view
- A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia · Full Atlas view
- A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) · Full Atlas view
- A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males · Full Atlas view
- A Study to Decrease Suicidal Thinking Using Ketamine · Full Atlas view
- A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder · Full Atlas view
- A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder · Full Atlas view
- A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia · Full Atlas view
- A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression · Full Atlas view
- A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression · Full Atlas view
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior · Full Atlas view
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression · Full Atlas view
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression · Full Atlas view
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression · Full Atlas view
- A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression · Full Atlas view
- A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder · Full Atlas view